Insulin Parenteral and Orphenadrine Extended-Release Tablets
Determining the interaction of Insulin Parenteral and Orphenadrine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Insulin (Parenteral)
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Parenteral-Orphenadrine Injection
- Insulin Parenteral-Orphenadrine w/A.C.
- Insulin Parenteral-Orphenadrine, aspirin, and caffeine
- Insulin Parenteral-Orphenate
- Insulin Parenteral-Orphengesic
- Insulin Parenteral-Orphengesic Forte
- Orphenadrine Extended-Release Tablets-Insulin regular
- Orphenadrine Extended-Release Tablets-Insulin Regular (U-100) Cartridges & Prefilled Syringes
- Orphenadrine Extended-Release Tablets-Insulin Regular (U-100) Vials
- Orphenadrine Extended-Release Tablets-Insulin Regular (U-500) Prefilled Pens
- Orphenadrine Extended-Release Tablets-Insulin Regular (U-500) Vials
- Orphenadrine Extended-Release Tablets-Insulin Regular IV Infusion